Clearside Biomedical, Inc. (CLSD)
Total Valuation
CLSD has a market cap or net worth of $63.03 million. The enterprise value is $76.03 million.
| Market Cap | 63.03M |
| Enterprise Value | 76.03M |
Important Dates
The last earnings date was Monday, November 13, 2023, after market close.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
CLSD has 62.41 million shares outstanding. The number of shares has increased by 2.98% in one year.
| Shares Outstanding | 62.41M |
| Shares Change (YoY) | +2.98% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 7.20% |
| Owned by Institutions (%) | 27.28% |
| Float | 53.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.51 |
| Forward PS | 23.94 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28
| Current Ratio | 5.28 |
| Quick Ratio | 5.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -88.00% |
| Return on Capital (ROIC) | -103.63% |
| Revenue Per Employee | $61,417 |
| Profits Per Employee | -$1.04M |
| Employee Count | 36 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.01% in the last 52 weeks. The beta is 2.18, so CLSD's price volatility has been higher than the market average.
| Beta (1Y) | 2.18 |
| 52-Week Price Change | -9.01% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 57.74 |
| Average Volume (30 Days) | 117,276 |
Short Selling Information
The latest short interest is 290,630, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 290,630 |
| Short Previous Month | 344,521 |
| Short % of Shares Out | 0.47% |
| Short % of Float | 0.54% |
| Short Ratio (days to cover) | 2.71 |
Income Statement
In the last 12 months, CLSD had revenue of $2.21 million and -$37.32 million in losses. Loss per share was -$0.61.
| Revenue | 2.21M |
| Gross Profit | 1.65M |
| Operating Income | -30.00M |
| Pretax Income | -37.32M |
| Net Income | -37.32M |
| EBITDA | -37.25M |
| EBIT | -37.32M |
| Loss Per Share | -$0.61 |
Balance Sheet
The company has $28.80 million in cash and $41.80 million in debt, giving a net cash position of -$12.99 million or -$0.21 per share.
| Cash & Cash Equivalents | 28.80M |
| Total Debt | 41.80M |
| Net Cash | -12.99M |
| Net Cash Per Share | -$0.21 |
| Equity / Book Value | -12.85M |
| Book Value Per Share | -0.21 |
| Working Capital | 24.98M |
Cash Flow
In the last 12 months, operating cash flow was -$24.24 million and capital expenditures -$1.75 million, giving a free cash flow of -$25.99 million.
| Operating Cash Flow | -24.24M |
| Capital Expenditures | -1.75M |
| Free Cash Flow | -25.99M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 74.72%, with operating and profit margins of -1,356.81% and -1,687.74%.
| Gross Margin | 74.72% |
| Operating Margin | -1,356.81% |
| Pretax Margin | -1,687.74% |
| Profit Margin | -1,687.74% |
| EBITDA Margin | -1,684.62% |
| EBIT Margin | -1,687.74% |
| FCF Margin | -1,175.26% |
Dividends & Yields
CLSD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -59.20% |
| FCF Yield | -41.22% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.98% |
| Shareholder Yield | -2.98% |
Analyst Forecast
The average price target for CLSD is $5.25, which is 419.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.25 |
| Price Target Difference | 419.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 126.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CLSD has an Altman Z-Score of -14.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.7 |
| Piotroski F-Score | 1 |